Evidence map›Paper›PMID 36382470›Full record

ArticleAlcohol and alcoholism (Oxford, Oxfordshire)2023

Ghrelin Predicts Stimulant and Sedative Effects of Alcohol in Heavy Drinkers.

Elizabeth Ralevski, Tamas L Horvath, Marya Shanabrough, Jenelle Newcomb, Emily Pisani, Ismene Petrakis

Open access · greenAbstract read
In one paragraph

Article in Alcohol and alcoholism (Oxford, Oxfordshire), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Elizabeth RalevskiDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, USA.
Tamas L HorvathProgram of Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven 06520, CT, USA.
Marya ShanabroughProgram of Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven 06520, CT, USA.
Jenelle NewcombDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, USA.
Emily PisaniDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, USA.
Ismene PetrakisDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, USA.
Yale University · USVA Connecticut Healthcare System · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale-SCORE Resource Support CoreU54AA027989 · NIAAA · YALE UNIVERSITY · PI Sherry Ann McKee · 2020 to 2026
$13.0M
Microglia as a Treatment Target for Alcohol Use DisorderR21AA023150 · NIAAA · YALE UNIVERSITY · PI PETRAKIS, ISMENE L., SOFUOGLU, MEHMET · 2015 to 2016
$344k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS R21 AA023150NIAAA NIH HHS U54 AA027989
6 · The paper itself

Abstract

aimThe aim of this study was to examine the relationship between ghrelin levels and the subjective effects of alcohol in heavy drinkers, and to compare them to healthy controls.

methodsGhrelin levels were collected as part of two laboratory studies. Both groups received either IV infusion of saline or high dose of alcohol (100 mg%). In the study of heavy drinkers, ghrelin was gathered on all subjects, but data was analyzed only for participants who received placebo (N=12). Healthy controls (N=20) came from another study that collected data on family history. Ghrelin levels and measures of alcohol effects (BAES, VAS, NDS, YCS [see manuscript for details]) were collected at 4 timepoints: baseline, before infusion, during infusion and after infusion.

resultsIV alcohol significantly reduced ghrelin levels and higher fasting ghrelin levels were associated with more intense subjective alcohol effects. There were no differences in fasting ghrelin levels or subjective effects between heavy drinkers and controls. However, while both groups showed similar decline in ghrelin levels following alcohol infusion, on the placebo day, ghrelin levels in the healthy subjects increased significantly and exponentially over time while for the heavy drinkers ghrelin levels remained flat.

conclusionsOur findings support the role of ghrelin in reward mechanisms for alcohol. Contrary to others, we found no differences in fasting ghrelin levels or subjective experiences of alcohol between heavy drinkers and healthy controls. However, the group differences on the IV placebo day may be a possible indication of ghrelin abnormalities in heavy drinkers.

Indexed as

Alcoholic IntoxicationHypnotics and SedativesAlcohol DrinkingEthanolGhrelinHumansEthanolGhrelinHypnotics and Sedatives

Identifiers

PMID36382470
PMCPMC9830489
OpenAlexW4309159289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.